CFN Media’s Exclusive Interview with Pascal Biosciences
November 8, 2018
Ryan Allway November 8th, 2018 Exclusive, News, Press Releases, Top Story The cannabis industry is projected to reach $75 billion by 2030, according to Cowen & Co., driven by the legalization of medical and recreational cannabis across a growing number of states. While many investors are familiar with... Read more
Pascal Biosciences Announces Optimization of Cannabinoid-Derived Drug Candidates to Kill Glioblastoma Cells
November 5, 2018
Ryan Allway November 5th, 2018 News, Press Releases VANCOUVER, British Columbia and SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the peer reviewed publication and upcoming presentation of their recently licensed cannabinoid-derived drug... Read more
Ryan Allway November 2nd, 2018 Uncategorized The cannabis industry is projected to reach $75 billion by 2030, according to Cowen & Co., driven by the legalization of medical and recreational cannabis across a growing number of states. According to Arcview Market Research and BDS Analytics, a large portion... Read more
Gabriella’s Kitchen Confirms Its Cannabis-Infused alto™ Products Have Launched in Northern California
November 2, 2018
GABY offers a variety of alto™ products including a line infused with cannabis-derived cannabinoids (including CBD and THC) which are part of GABY’s “better-for-you” edibles line, the first such line to be offered, representing an entirely new approach to cannabis-infused products. The initial alto™ products released consist of infused,... Read more
48North Cannabis Corp. Announces Transformational Acquisition and $10MM Private Placement
October 30, 2018
TORONTO, Oct. 30, 2018 /CNW/ – 48North Cannabis Corp. (“48North” or the “Company”) (TSXV:NRTH) and 2599708 Ontario Inc. (“Good & Green”) have entered into a letter agreement that became binding on October 29, 2018, whereby 48North will acquire all of the issued and outstanding common shares of privately-held Good &... Read more
Bloomberg Interviews FSD Pharma for Cannabis Shortage Feature
October 30, 2018
Ryan Allway October 30th, 2018 News, Top News Canada may have legalized adult-use cannabis on October 17, but that doesn’t mean consumers are able to purchase the drug. According to Bloomberg, there are widespread shortages across the country, despite an ample supply of licensed producers awaiting approval from... Read more
BLOCKStrain Addresses Cannabis Diversion & Inversion Challenges
October 29, 2018
Ryan Allway October 29th, 2018 News, Press Releases, Top News The U.S. cannabis industry is projected to reach $75 billion by 2030, according to Cowen & Co., driven by the legalization of medical and recreational cannabis across a growing number of states. At the same time, Deloitte believes... Read more
Ryan Allway October 26th, 2018 Exclusive, Feature Stories, News Canada’s cannabis industry could experience a dramatic windfall with the legalization of recreational cannabis in October, but many cannabis companies are looking beyond the borders for opportunities. In particular, the most progressive cannabis companies are building up both their... Read more
CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp.’s Leadership Position in Booming Canadian Cannabis Market
October 24, 2018
Ryan Allway October 24th, 2018 News, Press Releases CannabisNewsAudio announces the Audio Press Release (APR) titled “Canada Leads International Cannabis Boom – and It’s Not About Smoking,” featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP). To hear the CannabisNewsAudio version, visit: http://cnw.fm/7n7B5 To read the full editorial, visit:... Read more
In a little over two 60 days, the date Canadian cannabis investors have long been waiting for will finally be here. On October 17, recreational marijuana will officially go on sale in in the country, which follows the passage of the Cannabis Act in June. Canada will become the first industrialized... Read more
